Eli Lilly, which also will make the weight-loss medication Mounjaro and Zepbound, reported it designs to complete seven further stage 3 scientific trials of retatrutide in 2026, compiling details that will be submitted to the U.As with any prescription medication, folks must speak with a wellness care provider about regardless of whether any of the